SCHEMBL2606342

SCHEMBL2606342

Cc1cnc(NC(=O)N(C2CCCCC2)C2CCC(C(=O)O)CC2)s1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.57
RAB9A P51151 6/20 0.50
NPC1 O15118 5/20 0.50
GAA P10253 1/20 0.50
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 2/20 0.43
LMNA P02545 2/20 0.40
PKM P14618 2/20 0.40
EPHX2 P34913 1/20 0.40
CHKA P35790 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
TP53 P04637 1/20 0.39
PDF Q9HBH1 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1002294 0.92 SMN1; SMN2 (0.63) SMN1; SMN2RAB9ANPC1GAAMEN1
SCHEMBL2653739 0.91 SMN1; SMN2 (0.51) SMN1; SMN2RAB9ANPC1GAAMEN1
SCHEMBL2649136 0.87 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ANPC1GAAMEN1
SCHEMBL998432 0.86 SMN1; SMN2 (0.52) SMN1; SMN2RAB9ANPC1GAAMEN1
SCHEMBL2666146 0.86 SMN1; SMN2 (0.52) SMN1; SMN2RAB9ANPC1GAAMEN1
SCHEMBL999778 0.86 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1GAAMEN1
SCHEMBL999495 0.86 SMN1; SMN2 (0.56) SMN1; SMN2RAB9ANPC1GAAMEN1
SCHEMBL998509 0.85 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ANPC1GAAMEN1
SCHEMBL999145 0.83 SMN1; SMN2 (0.57) SMN1; SMN2RAB9ANPC1GAAMEN1
SCHEMBL998383 0.83 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ANPC1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444397-A1 Heteroaryl-ureas and their use as glucokinase activators Novo Nordisk A/S (DK) 2012-04-25 EP disclosed